U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric

Expand all

Fresenius Kabi USA, LLC (Reverified 07/16/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) Available Check wholesalers for inventory
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) Available Check wholesalers for inventory
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) Available Check wholesalers for inventory
Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) Available Check wholesalers for inventory
Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) Available Check wholesalers for inventory
Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) Available Check wholesalers for inventory

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) Unavailable Next Delivery: April 2025; Estimated Recovery: September 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) Unavailable Next Delivery: August 2024; Estimated Recovery: September 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) Unavailable Next Delivery: November 2024; Estimated Recovery: March 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) Unavailable Next Delivery: February 2025; Estimated Recovery: September 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) Available
Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) Unavailable Next Delivery and Estimated Recovery: March 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) Unavailable Next Delivery: July 2025; Estimated Recovery: September 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) Unavailable Next Delivery: July 2025; Estimated Recovery: September 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) Unavailable Next Delivery: July 2025; Estimated Recovery: September 2025 Demand increase for the drug
Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) Unavailable Next Delivery: February 2025; Estimated Recovery: March 2025 Demand increase for the drug
Back to Top